Newgenivf Group, an IVF service provider, disclosed in its Nasdaq filing that it bought 146,432 XRP tokens during 2025 and sold them all before year-end, earning $10,849 from the transactions. The company also traded Bitcoin, Ethereum, and Solana, with only Solana holdings remaining at year-end, showing a significant unrealized loss. This crypto activity is separate from its core IVF business and reflects a capital allocation strategy rather than operational revenue. Despite some realized gains, the firm reported a net loss due to Solana's price drop, highlighting the risks of corporate crypto investments.
A crypto commentator highlighted that historically, 92% of nine-month periods after U.S. midterm elections have seen market gains, averaging 19%, with the only negative period during the Great Depression. This pattern suggests potential positive mome...
The GENIUS Act, which became law in July 2025, could benefit XRP through Ripple's RLUSD stablecoin. Crypto researcher SMQKE highlighted that RLUSD transactions on the XRP Ledger generate small fees paid in XRP that are burned, potentially reducing su...
XRP experienced a 13.4% price drop in October from $1.49 to $1.29, even with $14.52 million in ETF inflows. The price retraced to a key demand zone around $1.25, which traders are watching for support. Despite growing wallet numbers and new holders, ...
Evernorth, which recently debuted on Nasdaq, holds 473 million XRP tokens and plans to use them across lending, liquidity, and institutional markets. This strategy aims to tap into markets worth trillions of dollars and increase the amount of XRP per...
XRP's price reaching $2 is delayed, with technical indicators like Bollinger Bands showing a prolonged sideways trend expected to last until 2028. Despite strong development in Ripple's infrastructure and legal clarity, steady monthly token releases ...
